Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Armand Van Deun

8 ta ish

Institute of Tropical Medicine Antwerp

AkademScholarda batafsil koʻrsatkichlar

  1. Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

    Armand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim +4

    MaqolaOchiq kirish201012 iqtibos
    ABI

  2. A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

    Andrew Nunn, Patrick Phillips, Sarah Meredith +16

    MaqolaOchiq kirish20196 iqtibos
    ABI

  3. High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses

    Alberto Piubello, Souleymane Hassane Harouna, Mahamadou Bassirou Souleymane +5

    Maqola20146 iqtibos
    ABI

  4. Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients

    K. J. M. Aung, Armand Van Deun, Erik De Clercq +4

    Maqola20146 iqtibos
    ABI

  5. Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries

    Arnaud Trébucq, V Schwoebel, Zacharie Kashongwe +15

    Maqola20176 iqtibos
    ABI

  6. Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial

    Andrew Nunn, I. D. Rusen, Armand Van Deun +6

    Maqola20142 iqtibos
    ABI

  7. Xpert<sup>®</sup> MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?

    Arnaud Trébucq, Donald A. Enarson, Chen‐Yuan Chiang +9

    Maqola20112 iqtibos
    ABI

  8. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

    S.K. Abidi, Jay Achar, M.M. Assao Neino +34

    MaqolaOchiq kirishTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 iqtibos
    ABI